NEW YORK, June 6 – In the first joint sale announced since their $5.5 million legal settlement, Genomic Solutions and PerkinElmer said Wednesday they had sold the GeneTac biochip system to the Indian Institute of Science in Bangalore, India.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.